1. Home
  2. RMD vs ALC Comparison

RMD vs ALC Comparison

Compare RMD & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • ALC
  • Stock Information
  • Founded
  • RMD 1989
  • ALC 1945
  • Country
  • RMD United States
  • ALC Switzerland
  • Employees
  • RMD N/A
  • ALC N/A
  • Industry
  • RMD Medical/Dental Instruments
  • ALC Ophthalmic Goods
  • Sector
  • RMD Health Care
  • ALC Health Care
  • Exchange
  • RMD Nasdaq
  • ALC Nasdaq
  • Market Cap
  • RMD 40.7B
  • ALC 43.2B
  • IPO Year
  • RMD 1995
  • ALC N/A
  • Fundamental
  • Price
  • RMD $281.83
  • ALC $81.37
  • Analyst Decision
  • RMD Buy
  • ALC Buy
  • Analyst Count
  • RMD 13
  • ALC 11
  • Target Price
  • RMD $276.82
  • ALC $96.73
  • AVG Volume (30 Days)
  • RMD 1.0M
  • ALC 2.4M
  • Earning Date
  • RMD 10-23-2025
  • ALC 08-19-2025
  • Dividend Yield
  • RMD 0.85%
  • ALC 0.27%
  • EPS Growth
  • RMD 37.43
  • ALC N/A
  • EPS
  • RMD 9.51
  • ALC 2.16
  • Revenue
  • RMD $5,146,327,000.00
  • ALC $10,025,000,000.00
  • Revenue This Year
  • RMD $9.83
  • ALC $6.21
  • Revenue Next Year
  • RMD $7.29
  • ALC $7.51
  • P/E Ratio
  • RMD $29.66
  • ALC $37.58
  • Revenue Growth
  • RMD 9.84
  • ALC 4.04
  • 52 Week Low
  • RMD $199.92
  • ALC $78.11
  • 52 Week High
  • RMD $293.81
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • RMD 52.05
  • ALC 40.01
  • Support Level
  • RMD $286.31
  • ALC $80.76
  • Resistance Level
  • RMD $293.81
  • ALC $82.77
  • Average True Range (ATR)
  • RMD 4.56
  • ALC 1.45
  • MACD
  • RMD -1.23
  • ALC -0.56
  • Stochastic Oscillator
  • RMD 15.63
  • ALC 26.50

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: